Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Fadanafil in Healthy Chinese Males
NCT04312568Phase 1Completed
- Sponsor
- Sihuan Pharmaceutical
- Start
- Aug 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in erectile dysfunction (ED) and benign prostatic hyperplasia (BPH) comparing Fadanafil with Placebo (2 arms). Primary endpoints: Electrocardiogram at 46 hours, Area Under the Curve (0-24h) and 2 more. Started Aug 2018; status: completed.
02
Drugs
Fadanafil
03
Conditions
erectile dysfunction (ED)benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT04312568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04312568.